Richard Morris
Director of Finance/CFO chez CARISMA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Richard Steven Morris is currently the Chief Financial Officer at CTx Operations, Inc. and Carisma Therapeutics, Inc. He previously held positions as the VP-Financial Planning & Strategic Analysis at Shire ViroPharma, Inc. from 2012 to 2014, the Chief Financial Officer at Vitae Pharmaceuticals LLC from 2014 to 2016, the Chief Financial Officer at Passage Bio, Inc. from 2019 to 2021, and the Chief Financial Officer & Executive Vice President at Context Therapeutics LLC from 2017 to 2019.
He obtained his undergraduate degree from St. Joseph's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Richard Morris
| Sociétés | Poste | Début |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/06/2021 |
Anciens postes connus de Richard Morris
| Sociétés | Poste | Fin |
|---|---|---|
| PASSAGE BIO, INC. | Director of Finance/CFO | 30/05/2021 |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | 01/07/2019 |
| VITAE PHARMACEUTICALS INC | Director of Finance/CFO | 25/10/2016 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Comptroller/Controller/Auditor | 25/06/2012 |
Formation de Richard Morris
| St. Joseph's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PASSAGE BIO, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
